Figure 2From: The global pediatric antiretroviral market: analyses of product availability and utilization reveal challenges for development of pediatric formulations and HIV/AIDS treatment in children Trends in innovator and generic pediatric ARV formulations certified by WHO and FDA*. *Includes all pediatric ARV approvals for all manufacturers; overlap between FDA approval and WHO prequalification exists as some products are certified by both organizations.Back to article page